HC Wainwright Has Negative Outlook for SLNO Q1 Earnings
Soleno Therapeutics, Inc. (NASDAQ:SLNO - Free Report) - Analysts at HC Wainwright reduced their Q1 2025 earnings estimates for shares of Soleno Therapeutics in a research note issued to investors on Monday, March 3rd. HC Wainwright analyst R. Selvaraju now forecasts that the company will earn ($0.
Publicado el: 2025-03-07 12:03:16
Autor: lulegacy, Fuente: lulegacy
Compartir: 
